Yüklüyor......
Disruption of the AKT Pathway Inhibits Metastasis in an Orthotopic Model of Head and Neck Squamous Cell Carcinoma
INTRODUCTION: Merck's MK-2206 is an orally active, allosteric inhibitor of AKT; a component of the phosphatidylinositol-3 kinase (PI3K) pathway. The PI3K-AKT pathway is a downstream signaling pathway that has recently been found to play an important role in head and neck squamous cell carcinoma...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3396129/ https://ncbi.nlm.nih.gov/pubmed/22020886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.22180 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|